Sofosbuvir/Velpatasvir for Patients with Chronic Genotype 3 HCV Infection with Compensated Cirrhosis: An Integrated Analysis of Phase 2 and Phase 3 Clinical Trials

被引：0

作者：

Roberts, Stuart Keith ^{[1
]}

Buti, Maria ^{[2
]}

Foster, Graham R. ^{[3
]}

Luis Calleja, Jose ^{[4
]}

Sood, Ajit ^{[5
]}

Isakov, Vasily A. ^{[6
]}

Ola, R.

Weiland, Hj ^{[7
]}

Stamm, Luisa ^{[8
]}

Ni, Liyun ^{[8
]}

Svarovskaia, Evguenia ^{[8
]}

Brainard, Diana ^{[8
]}

Wyles, David L. ^{[9
]}

Antonio Pineda, Juan ^{[10
]}

Thompson, Alexander ^{[11
]}

Esteban, Rafael ^{[12
]}

Mangia, Alessandra ^{[13
]}

机构：

[1] Alfred Hosp, Melbourne, Vic, Australia

[2] Hosp Univ Vall dHebron, Barcelona, Spain

[3] Queen Mary Univ London, London, England

[4] Hosp Univ Puerta De Hierro, Madrid, Spain

[5] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India

[6] Russian Acad Med Sci, Moscow, Russia

[7] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden

[8] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[9] Denver Hlth Med Ctr, Denver, CO USA

[10] Hosp Univ Virgen De Valme, Seville, Spain

[11] St Vincents Hosp Melbourne, Dept Gastroenterol, Melbourne, Vic, Australia

[12] Vall Dhebron Univ Hosp, Dept Internal Med, Liver Unit, Barcelona, Spain

[13] Osped Casa Sollievo Sofferenza, IRCCS, San Giovanni Rotondo, Italy

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

628

引用

页码：373A / 374A

页数：2